Healthcare Global Liquid Biopsy Market | Page 2

“Global Liquid Biopsy Market Analysis & Opportunity
Outlook 2021”
Liquid biopsy is a non-invasive and simple alternative of conventional
surgical biopsies that enable medical professionals to detect cancer causing
tambours just by taking the blood sample of the patient. In this manner,
liquid biopsy assists the doctors in selecting the correct treatment
procedure for patients at right time. Rising number of cancer patients in
the world coupled with innovation in liquid biopsy technology is
anticipated to drive the global liquid biopsy market over the forecast
period.
Global Liquid Biopsy Market is expected to flourish at a CAGR of
25.0% over the forecast period. Moreover, the global liquid biopsy market is
anticipated to garner USD 10,850 Million by the end of 2021. Factors such
as increasing penetration of cancer, rising awareness regarding the
detection of cancer, increasing healthcare expenditure are anticipated to be
the dynamic factor behind the growth of liquid biopsy market.
North America dominates the global liquid biopsy market. It is projected
that by 2016 end, 1.7 million new cancer cases would be detected in the U.S.
alone, making the country a major market for liquid biopsy in North
America. Asia-Pacific liquid biopsy market is likely to behold the highest
CAGR during the forecast period i.e. 2015-2021. Rising per capita income
and increasing investments on healthcare infrastructure are some of the
major factors which are projected to bolster liquid biopsy market in
countries such as India and China.
Copyright © Research Nester
www.researchnester.com